Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 3, Pages 751
Publisher
MDPI AG
Online
2020-03-25
DOI
10.3390/cancers12030751
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
- (2019) Christopher T. Petersen et al. Frontiers in Oncology
- Virus-Based Immunotherapy of Glioblastoma
- (2019) Miika Martikainen et al. Cancers
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
- (2019) Kurt A. Schalper et al. NATURE MEDICINE
- Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
- (2019) Stephanie L. Goff et al. JOURNAL OF IMMUNOTHERAPY
- Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) + radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM).
- (2019) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma.
- (2019) Bart Neyns et al. JOURNAL OF CLINICAL ONCOLOGY
- Defining EGFR amplification status for clinical trial inclusion
- (2019) Pim J French et al. NEURO-ONCOLOGY
- Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
- (2019) Bracha Shraibman et al. MOLECULAR & CELLULAR PROTEOMICS
- Potential for Nuclear Medicine Therapy for Glioblastoma Treatment
- (2019) Clément Bailly et al. Frontiers in Pharmacology
- Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
- (2019) Weilei Hu et al. Frontiers in Immunology
- B7-H3 as a novel CAR-T therapeutic target for glioblastoma
- (2019) Xin Tang et al. Molecular Therapy-Oncolytics
- Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study
- (2019) Kaspar Draaisma et al. JOURNAL OF CLINICAL ONCOLOGY
- Longitudinal molecular trajectories of diffuse glioma in adults
- (2019) Floris P. Barthel et al. NATURE
- Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens
- (2019) Bas Weenink et al. Scientific Reports
- CRISPR/Cas9-mediated knockout of DGK improves anti-tumor activities of human T cells
- (2018) In-Young Jung et al. CANCER RESEARCH
- IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma
- (2018) Erik Ladomersky et al. CLINICAL CANCER RESEARCH
- Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes
- (2018) Malte Mohme et al. CLINICAL CANCER RESEARCH
- T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
- (2018) Karolina Woroniecka et al. CLINICAL CANCER RESEARCH
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- Multidimensional communication in the microenvirons of glioblastoma
- (2018) Marike L. Broekman et al. Nature Reviews Neurology
- Temozolomide-associated hypermutation in gliomas
- (2018) Serah Choi et al. NEURO-ONCOLOGY
- Immunotherapy in CNS cancers: the role of immune cell trafficking
- (2018) Nivedita M Ratnam et al. NEURO-ONCOLOGY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cell–induced CSF1 promotes melanoma resistance to PD1 blockade
- (2018) Natalie J. Neubert et al. Science Translational Medicine
- Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy
- (2018) Serena Pellegatta et al. Science Translational Medicine
- Viral sequences in human cancer
- (2018) Paul G. Cantalupo et al. VIROLOGY
- Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide
- (2018) Serena Pellegatta et al. OncoImmunology
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
- (2018) Hussein A. Tawbi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Checkpoint blockade reverses anergy in IL13Rα2 humanized scFv based CAR T cells to treat murine and canine gliomas.
- (2018) Yibo Yin et al. Molecular Therapy-Oncolytics
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Finding the Right Way to Target EGFR in Glioblastomas; Lessons from Lung Adenocarcinomas
- (2018) Ya Gao et al. Cancers
- Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine
- (2017) David Capper et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL
- (2017) Zachary J. Roberts et al. LEUKEMIA & LYMPHOMA
- Immunosuppressive Myeloid Cells’ Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy
- (2017) Neha Kamran et al. MOLECULAR THERAPY
- Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
- (2017) Kevin Bielamowicz et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
- (2017) Quinn T Ostrom et al. NEURO-ONCOLOGY
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143
- (2017) D. A. Reardon et al. NEURO-ONCOLOGY
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
- (2017) Giedre Krenciute et al. Cancer Immunology Research
- The Role of Microglia and Macrophages in CNS Homeostasis, Autoimmunity, and Cancer
- (2017) Jie Yin et al. Journal of Immunology Research
- Tumor-infiltrating lymphocytes (TILs) from patients with glioma
- (2017) Zhenjiang Liu et al. OncoImmunology
- The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8 + T Cell Anti-tumor Activity
- (2017) Anne Kleijn et al. Molecular Therapy-Oncolytics
- Anti-GITR therapy promotes immunity against malignant glioma in a murine model
- (2016) Jason Miska et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses
- (2016) Leandro M. Colli et al. CANCER RESEARCH
- Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization
- (2016) Matthias Holdhoff et al. CLINICAL CANCER RESEARCH
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune phenotypes predict survival in patients with glioblastoma multiforme
- (2016) Haouraa Mostafa et al. Journal of Hematology & Oncology
- The role of microglia and macrophages in glioma maintenance and progression
- (2016) Dolores Hambardzumyan et al. NATURE NEUROSCIENCE
- A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
- (2016) Alba A. Brandes et al. NEURO-ONCOLOGY
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy
- (2016) T. M. Johanns et al. Cancer Discovery
- Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
- (2016) Anja Derer et al. Frontiers in Immunology
- Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?
- (2016) Valérie Dutoit et al. Frontiers in Oncology
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
- (2015) J. Schuster et al. NEURO-ONCOLOGY
- Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas
- (2015) Martin J. van den Bent et al. NEURO-ONCOLOGY
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transforming growth factor-β pathway activity in glioblastoma
- (2015) Karl Frei et al. Oncotarget
- Microenvironmental Clues for Glioma Immunotherapy
- (2014) Michael Platten et al. Current Neurology and Neuroscience Reports
- Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
- (2014) Carolien A. Koks et al. INTERNATIONAL JOURNAL OF CANCER
- Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs
- (2014) Lei Lu et al. Journal of Translational Medicine
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- Epidermal growth factor receptor and variant III targeted immunotherapy
- (2014) K. L. Congdon et al. NEURO-ONCOLOGY
- Transforming growth factor-beta and its implication in the malignancy of gliomas
- (2014) Laurent-Olivier Roy et al. Targeted Oncology
- Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
- (2013) Jing Zeng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
- (2013) Justyna Kmiecik et al. JOURNAL OF NEUROIMMUNOLOGY
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
- (2013) Silvia C. Formenti et al. JNCI-Journal of the National Cancer Institute
- Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
- (2013) David A. Nathanson et al. SCIENCE
- Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy
- (2012) C. A. Crane et al. NEURO-ONCOLOGY
- A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma
- (2012) John H. Sampson et al. PLoS One
- Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-
- (2011) J. Lohr et al. CLINICAL CANCER RESEARCH
- CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival
- (2010) Isaac Yang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance and mechanism of Treg infiltration in human brain tumors
- (2010) Joannes F.M. Jacobs et al. JOURNAL OF NEUROIMMUNOLOGY
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
- (2010) J. H. Sampson et al. NEURO-ONCOLOGY
- Characteristics of compounds that cross the blood-brain barrier
- (2009) William A Banks BMC Neurology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started